We have updated our Privacy Policy. You can find out more here.
For Equine Vets Everywhere

News and Views

This area allows you to:

  • View latest news items and search for older stories by keywords or category.
  • Keep up to date with BEVA Blog, maybe even contributing yourself. Email us for more information

Search News

News Archive

From the monthly archives: July 2018

We are pleased to present below all posts archived in 'July 2018'. If you still can't find what you are looking for, try using the search box.

BEVA urges VMD to overturn suspension of flunixin

The Veterinary Medicines Directorate (VMD) yesterday suspended the sale of all injectable formulations of the vital painkiller flunixin, without warning or consultation with the veterinary profession. Flunixin is the most commonly used analgesic in horses with colic, undergoing surgery and for other conditions. The British Equine Veterinary Association (BEVA) is calling for the suspension to be overturned in horses not destined for the human food chain, to reduce the potential impact on equine welfare. Flunixin is used throughout the equine veterinary profession because of its highly potent analgesic effects. It is the only medicine licensed for the treatment of sepsis (endotoxaemia). The VMD’s decision reflects European Medicines Agency guidance relating to the human safety of the solvent used in the injectable formulation, not the active ingredient. To date, no recall notices have been issued and therefore veterinary surgeons may continue to prescribe medicines held in stock, although disruption to ...

Best practice worm control advice following discontinuation of “Equitape” horse wormer in October 2018

From October 2018 the wormer brand, Equitape®, commonly used to treat tapeworm infection will be discontinued from sale in the UK. This wormer is the only licenced product for horses containing praziquantel as a single active ingredient. Going forward it will only be available in ‘combination wormers’ also containing either ivermectin or moxidectin, the drugs most commonly used to treat small and large redworm (strongyles). Equitape’s removal from the portfolio of veterinary medicines available to target specific worm infection presents a challenge to prescribers and horse owners alike.

Get in on the act at BEVA Congress

BEVA is inviting delegates to get in on the act at this year’s Congress 12-15 September 2018, with a series of role play sessions to help them get to grips with managing some of the notoriously difficult situations encountered in equine practice.

EVJ celebrates 50 years

2018 marks The Equine Veterinary Journal’s (EVJ) 50th year. To celebrate, the influential flagship journal for the British Equine Veterinary Association has published a series of special review articles in six priority areas. These document the scientific progress that has been made in equine veterinary science over the past half century. Guest-edited by Leo Jeffcott, Professor Emeritus of Veterinary Science at the University of Sydney, Australia, the series covers mare reproductive performance, laryngeal neuropathy, anaesthesia, colic surgery, osteochondrosis and in vitro embryo production.